Neutrophil cytosolic factor 1

NCF1
Identifiers
AliasesNCF1, NCF1A, NOXO2, SH3PXD1A, p47phox, Neutrophil cytosolic factor 1, CGD1
External IDsOMIM: 608512; MGI: 97283; GeneCards: NCF1
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000265

NM_001286037
NM_010876

RefSeq (protein)

NP_000256

NP_001272966
NP_035006

Location (UCSC)Chr 7: 74.77 – 74.79 MbChr 5: 134.25 – 134.26 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Neutrophil cytosol factor 1, also known as p47phox, is a protein that in humans is encoded by the NCF1 gene.

Function

The protein encoded by this gene is a 47 kDa cytosolic subunit of neutrophil NADPH oxidase. This oxidase is a multicomponent enzyme that is activated to produce superoxide anion. Mutations in this gene have been associated with chronic granulomatous disease.

Genetic variability in the NCF1 gene has been found to be related to a higher chance of getting autoimmune diseases such as Sjögren's syndrome, rheumatoid arthritis and lupus erythematosus.

Interactions

Neutrophil cytosolic factor 1 has been shown to interact with:

Therapies

A Phase 1/2 open-label clinical trial began in the U.S. in late 2024 to evaluate PM359, a gene therapy developed by Prime Medicine, in patients with chronic granulomatous disease caused by mutations in the NCF1 gene.